Peter Clare - Carlyle Director
CG Stock | USD 52.70 0.82 1.53% |
Director
Mr. Peter J. Clare serves as CoChief Investment Officer, CoHead of the U.S. Buyout Group and Director of Carlyle Group Management L.L.C. a General Partner of the Company. Mr. Clare is the CoChief Investment Officer of Carlyle and is CoHead of the U.S. Buyout group. Mr. Clare also serves on Carlyle Executive Group. Mr. Clare previously served as Deputy Chief Investment Officer of the Partnerships CPE segment. From 1999 to 2001, Mr. Clare was based in Hong Kong and was a founding member of the Carlyle Asia Buyout team and continues to serve on the Carlyle Asia Buyout Investment Committee. In 2001 and 2002, Mr. Clare launched Carlyles initial investments in distressed debt, which led to the creation of Carlyle Strategic Partners. From 2004 to 2011, Mr. Clare served as the Global Head of the Aerospace, Defense Government Services sector team. Prior to joining Carlyle, Mr. Clare was with First City Capital Corporationrationration, a private equity group that invested in buyouts, public equities, distressed bonds and restructurings. Prior to joining First City Capital, he was with the Merchant Banking Group of PrudentialBache. Mr. Clare is currently a member of the Boards of Directors of Booz Allen Hamilton and several private U.S. buyout portfolio companies. Mr. Clare has previously served on the boards of CommScope, Inc., Pharmaceutical Product Development and Signode Industrial. Mr. Clare serves on the Board of Directors of Georgetown University since 2018.
Age | 59 |
Tenure | 6 years |
Professional Marks | MBA |
Address | 1001 Pennsylvania Avenue, NW, Washington, DC, United States, 20004-2505 |
Phone | (202) 729-5626 |
Web | https://www.carlyle.com |
Carlyle Management Efficiency
The Carlyle's current Return On Tangible Assets is estimated to increase to -0.03. The current Return On Capital Employed is estimated to decrease to 0.09. At this time, Carlyle's Net Tangible Assets are most likely to decrease significantly in the upcoming years. The Carlyle's current Intangibles To Total Assets is estimated to increase to 0.04, while Non Current Assets Total are projected to decrease to roughly 1.2 B. Carlyle's management efficiency ratios could be used to measure how well Carlyle manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
Return On Equity | 0.0301 | ||||
Return On Asset | 0.0089 |
Carlyle Group Leadership Team
Elected by the shareholders, the Carlyle's board of directors comprises two types of representatives: Carlyle inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carlyle. The board's role is to monitor Carlyle's management team and ensure that shareholders' interests are well served. Carlyle's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carlyle's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amit Jain, Managing Advisors | ||
Deborah Polites, Chief Officer | ||
Sanket Patel, Principal CFO | ||
Bruce Larson, Senior Advisor | ||
Christopher Finn, Senior Advisor | ||
MBA CFA, Chief Solutions | ||
Charles Andrews, Chief Officer | ||
William Conway, Co-Founder, Co-CEO, Managing Director, Chief Investment Officer, Director of Carlyle Group Management LLC, Member of Management Committee and Member of Executive Committee | ||
Pooja Goyal, Chief Partner | ||
Susan Bass, Principal Equity | ||
CPA Hance, Operating Director | ||
Lindsay Lobue, MD COO | ||
Harvey Schwartz, CEO Director | ||
Daniel DAniello, CoFounder Emeritus | ||
Joshua Pang, MD Infrastructure | ||
Peter Clare, Co-Chief Investment Officer, Co-Head of the U.S. Buyout Group and Director of Carlyle Group Management L.L.C. | ||
Curtis CPA, Chief Officer | ||
David JD, CoFounder CoChairman | ||
John Redett, CFO Strategy | ||
Jeffrey Ferguson, MD Counsel | ||
Kapil CFA, Managing Partner | ||
SeokDon Chu, MD Manager |
Carlyle Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Carlyle a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0301 | ||||
Return On Asset | 0.0089 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.32 % | ||||
Current Valuation | 27.02 B | ||||
Shares Outstanding | 357.68 M | ||||
Shares Owned By Insiders | 27.65 % | ||||
Shares Owned By Institutions | 59.43 % | ||||
Number Of Shares Shorted | 10.62 M | ||||
Price To Earning | 6.52 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carlyle Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Carlyle. If investors know Carlyle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Carlyle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.409 | Dividend Share 1.4 | Earnings Share 0.3 | Revenue Per Share 12.899 | Quarterly Revenue Growth 3.192 |
The market value of Carlyle Group is measured differently than its book value, which is the value of Carlyle that is recorded on the company's balance sheet. Investors also form their own opinion of Carlyle's value that differs from its market value or its book value, called intrinsic value, which is Carlyle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Carlyle's market value can be influenced by many factors that don't directly affect Carlyle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Carlyle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Carlyle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Carlyle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.